Neurocrine Biosciences (NBIX) Current Deferred Revenue (2010 - 2017)
Neurocrine Biosciences (NBIX) posted quarterly Current Deferred Revenue of $513000.0 for Q1 2017, up 48.7% year-over-year from $345000.0 in Q1 2016, and up 9.15% on a QoQ basis from $470000.0 in Q4 2016.
Neurocrine Biosciences (NBIX) Current Deferred Revenue (2010 - 2017) Analysis & Trends
Neurocrine Biosciences has reported Current Deferred Revenue for 8 years, with the latest figure at $513000.0 in Q1 2017.
- Current Deferred Revenue for Q1 2017 came in at $513000.0, up 48.7% year-over-year; the trailing twelve-month figure through Mar 2017 was $513000.0 (up 48.7% YoY), and the FY2016 annual result was $470000.0, down 95.39% from the prior year.
- Current Deferred Revenue improved to $513000.0 in Q1 2017, from $470000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $10.2 million in Q1 2015 and troughed at $52000.0 in Q2 2014.
- A 5-year average of $1.8 million and a median of $428000.0 in 2016 frame the typical range for Current Deferred Revenue.
- The widest annual swing landed in 2015, when Current Deferred Revenue soared 8471.43%; it then slumped 96.62% in 2016.
- A 5-year view of Current Deferred Revenue shows it stood at $730000.0 in 2013, then plunged by 83.7% to $119000.0 in 2014, then soared by 8471.43% to $10.2 million in 2015, then sank by 95.39% to $470000.0 in 2016, then climbed by 9.15% to $513000.0 in 2017.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $513000.0 in Q1 2017, $470000.0 in Q4 2016, and $428000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 513,000.00 |
| Dec 31, 2016 | 470,000.00 |
| Sep 30, 2016 | 428,000.00 |
| Jun 30, 2016 | 386,000.00 |
| Mar 31, 2016 | 345,000.00 |
| Dec 31, 2015 | 10.20 Mn |
| Sep 30, 2015 | 232,000.00 |
| Jun 30, 2015 | 197,000.00 |
| Mar 31, 2015 | 10.20 Mn |
| Dec 31, 2014 | 119,000.00 |
| Sep 30, 2014 | 85,000.00 |
| Jun 30, 2014 | 52,000.00 |
| Sep 30, 2013 | 730,000.00 |
| Jun 30, 2013 | 1.46 Mn |
| Mar 31, 2013 | 2.19 Mn |
| Dec 31, 2012 | 2.92 Mn |
| Sep 30, 2012 | 10.18 Mn |
| Jun 30, 2012 | 17.44 Mn |
| Mar 31, 2012 | 25.74 Mn |
| Dec 31, 2011 | 34.24 Mn |